Lab Canada - * Printer friendly version * Email story to a friend * Send ... - 0 views
-
Assunta Krehl on 23 Dec 09To improve early detection and treatment of cancer, a pair of Toronto scientists, Dr David Jaffray, a senior scientist in the division of biophysics and bioimaging at the Ontario Cancer Institute and Dr Christine Allen, an associate professor in the Leslie Dan Faculty of Pharmacy at the University of Toronto has developed a technology that combines contrast agents with targeted, long-lasting nano-particles for use in multiple medical imaging platforms. MaRS Innovation (MI) and the University Health Network (UHN) have now entered into an agreement to collaboratively commercialize this promising technology. Dec 23, 2009